Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07168148 · ClinicalTrials.gov registry record · Phase 2
Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants
A Phase 2 study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT07168148: Clinical Trial Phase 2 study, sponsored by Washington University School of Medicine.
NCT07168148 is a Phase 2 study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 3 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07168148, a Phase 2 study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
This prospective, virtually administered trial conducted throughout the United States aims to evaluate a standardized protocol including the serial dilution of topical decongestants with concurrent topical steroids (triamcinolone), for elimination of dependence on topical decongestants.
Primary Outcome
The primary outcome measure will be the responder rate, defined as the percentage of participants who are able to discontinue decongestant use by the end of the study period and report that their symptoms are well-controlled, indicated by a score of 4 or less on the CGI-S.
Interventions
- DRUG Oxymetazoline + Triamcinolone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2025-11-10 |
| Est. Completion | 2026-03-19 |
| Phase | Phase 2 |
Why NCT07168148 stopped before completion
NCT07168148 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Oxymetazoline + Triamcinolone is the first listed.
NCT07168148 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07168148 about?
NCT07168148 is a clinical study titled "Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants". This prospective, virtually administered trial conducted throughout the United States aims to evaluate a standardized protocol including the serial dilution of topical decongestants with concurrent topical steroids (triamcinolone), for elimination of dependence on topical decongestants.
What is the current status of trial NCT07168148?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2025-11-10. Estimated completion is 2026-03-19.
What interventions are being tested in trial NCT07168148?
The interventions under investigation include: Oxymetazoline + Triamcinolone (DRUG).
Who is sponsoring clinical trial NCT07168148?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07168148's enrollment target sits among peer trials
3 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI